DexCom stock was on the rise Thursday after the maker of medical technology said it had received clearance from the U.S. Food ...

Science Connected Magazine is an editorially independent, non-profit newsroom producing open-access science journalism and ...

Dexcom launched its next-generation continuous glucose monitor on Monday. But Dexcom stock inched down a fraction. Please ...

Through this collaboration, Glucotrack will leverage next-generation artificial intelligence and machine learning-based analytics to evaluate clinical study data from its Continuous Blood Glucose ...

Glucotrack, Inc. announced that it will present safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system at the 2025 International ...

The letter also noted that the company does not monitor how acetaminophen affects glucose sensing with its G7 monitors. The FDA also said Dexcom is not properly evaluating the risk of using the G6 ...

will ingest glucose data from Dexcom G7 Continuous Glucose Monitoring Systems (CGM) time synchronously alongside Nanowear’s previously FDA cleared cardiovascular biomarkers. The continuous ...

The 15.5-day Dexcom G7 continuous glucose monitor (CGM) demonstrated high accuracy and safety in adults with diabetes, meeting and exceeding integrated CGM performance goals.